27 related articles for article (PubMed ID: 20873589)
1. Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer.
Sarkar P; Malik S; Banerjee A; Datta C; Pal DK; Ghosh A; Saha A
Front Cell Infect Microbiol; 2022; 12():894777. PubMed ID: 35865814
[TBL] [Abstract][Full Text] [Related]
2. [Differentially expressed genes in prostate cancer and benign prostatic hyperplasia].
Zhang T; Xu Y; Tang H; Liu M; Ren D; Niu Y
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):897-9. PubMed ID: 15638016
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
Alonso V; Neves AF; Marangoni K; Faria PC; Freschi AP; Capaneli AC; Meola J; Goulart LR
Cancer Detect Prev; 2009; 32(4):336-7. PubMed ID: 19026495
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
6. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
7. [Serum cytokine profiling of prostate cancer and benign prostatic hyperplasia using recombinant antibody microarray].
Zhang L; Sun SK; Shi LX; Zhang X
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):584-8. PubMed ID: 20873589
[TBL] [Abstract][Full Text] [Related]
8. Fingerprinting the diseased prostate: associations between BPH and prostate cancer.
Shah US; Getzenberg RH
J Cell Biochem; 2004 Jan; 91(1):161-9. PubMed ID: 14689588
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in prostate hyperplasia and carcinogenesis.
Udensi UK; Tchounwou PB
J Exp Clin Cancer Res; 2016 Sep; 35(1):139. PubMed ID: 27609145
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostate.
Keil KP; Vezina CM
Epigenomics; 2015; 7(3):413-25. PubMed ID: 26077429
[TBL] [Abstract][Full Text] [Related]
11. [Gene regulation of prostaglandin synthase and prostate diseases].
Wu SS; Wu JH; Sun ZY
Zhonghua Nan Ke Xue; 2017 Jul; 23(7):663-667. PubMed ID: 29723463
[TBL] [Abstract][Full Text] [Related]
12. Search for Novel Diagnostic Biomarkers of Prostate Inflammation-Related Disorders: Role of Transglutaminase Isoforms as Potential Candidates.
Savoca MP; Inferrera A; Verderio EAM; Caccamo D
Mediators Inflamm; 2019; 2019():7894017. PubMed ID: 31360119
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
